Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
In 1986, Kärre and colleagues reported that natural killer (NK) cells rejected an MHC class I-deficient tumor cell line (RMA-S) but they did not reject the same cell line if it expressed MHC class I (RMA). Based on this observation, they proposed the concept that NK cells provide immune surveillance for “missing self,” e.g., they eliminate cells that have lost class I MHC antigens. This seminal observation predicted the existence of inhibitory NK cell receptors for MHC class I. Here, we present evidence that NK cells are able to reject tumors expressing MHC class I if the tumor expresses a ligand for NKG2D. Mock-transfected RMA cells resulted in tumor formation. In contrast, when RMA cells were transfected with the retinoic acid early inducible gene-1 γ or δ (RAE-1), ligands for the activating receptor NKG2D, the tumors were rejected. The tumor rejection was mediated by NK cells, and not by CD1-restricted NK1.1 + T cells. No T cell-mediated immunological memory against the parental tumor was generated in the animals that had rejected the RAE-1 transfected tumors, which succumbed to rechallenge with the parental RMA tumor. Therefore, NK cells are able to reject a tumor expressing RAE-1 molecules, despite expression of self MHC class I on the tumor, demonstrating the potential for NK cells to participate in immunity against class I-bearing malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“NKG2D has been implicated in immune surveillance of tumors using transgenic models of spontaneous cancer as well as subcutaneous tumor transfer models (Cerwenka et al., 2001; Diefenbach et al., 2001; Guerra et al., 2008).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Cerwenka et al., 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Self-citationBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Self-citationCosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
Self-citationBroad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
Research works printed but not linked: 2
- 10.1146/annurev.iy.10.040192.001201 · doi:10.1146/annurev.iy.10.040192.001201 · Paper page
- S Bahram Adv Immunol 76, 1–60 (2000).
Cited by
Items 401–500 of 691
Djelloul, M., Popa, N., Pelletier, F., Raguénez, G., & Boucraut, J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.147 · Cited by 20
Pahl, J. H. W., Ruslan, S. E. N., Kwappenberg, K. M. C., Dam, M. M. V. O.-T., van Tol, M. J. D., Lankester, A. C., & Schilham, M. W. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1406-x · Cited by 20
Hu, B., Bao, G., Zhang, Y., Lin, D., Wu, Y., Wu, D., & Liu, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103199 · Cited by 20
shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
Subrakova, V. G., Kulemzin, S. V., Николаевна, Б. Т., Chikaev, A. N., Chikaev, N. A., Koval, O. A., Gorchakov, A. A., & Taranin, A. V. (2020) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj20.598 · Cited by 20
Zwirner, N. W., Fuertes, M. B., Girart, M. V., Domaica, C. I., & Rossi, L. E. (2006) · Cited by 20
Mou, X., Zhou, Y., Jiang, P., Zhou, T., Jiang, Q., Xu, C., Liu, H., Zheng, T., Yuan, G., Zhang, Y., et al. (2014) · Scientific Reports · doi:10.1038/srep06138 · Cited by 19
Natural Killer Cell-Mediated Shedding of ULBP2
Wang, R., & Sun, P. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091133 · Cited by 18
Picardi, A., Mengarelli, A., Marino, M., Gallo, E., Benevolo, M., Pescarmona, E. O., Cocco, R., Fraioli, R., Tremante, E., Petti, M. C., et al. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0213-y · Cited by 18
Decline in peripheral blood NKG2D+CD3+CD56+ NKT cells in metastatic colorectal cancer patients
Gharagozloo, M., Rezaei, A., Kalantari, H., Bahador, A., Hassannejad, N., Maracy, M. R., Nouri, N., Sedghi, M., Ghazanfari, H., & Bayat, B. (2018) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2018_002 · Cited by 18
NKG2D‐ligands: Putting everything under the same umbrella can be misleading
Campos‐Silva, C., Kramer, M. K., & Valés‐Gómez, M. (2018) · HLA · doi:10.1111/tan.13246 · Cited by 18
Arming cytotoxic lymphocytes for cancer immunotherapy by means of the NKG2D/NKG2D-ligand system
Lazarova, M., Wels, W. S., & Steinle, A. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1803273 · Cited by 18
Redirecting NK cells mediated tumor cell lysis by a new recombinant bifunctional protein
Germain, C., Campigna, E., Salhi, I., Morisseau, S., Navarro‐Teulon, I., Mach, J. P., Pèlegrin, A., & Robert, B. (2008) · Protein Engineering Design and Selection · doi:10.1093/protein/gzn047 · Cited by 18
A role for the MHC class I‐like Mill molecules in nutrient metabolism and wound healing
Rabinovich, B. A., Ketchem, R. R., Wolfson, M. F., Goldstein, L. C., Skelly, M., & Cosman, D. J. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.41 · Cited by 18
Physical Activity, Dietary Calorie Restriction, and Cancer
McTiernan, A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7551-5 · Cited by 17
Hömberg, N., Adam, C., Riedel, T., Brenner, C., Flatley, A., Röcken, M., & Mocikat, R. (2014) · International Journal of Cancer · doi:10.1002/ijc.28932 · Cited by 17
Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment
Orrantia, A., Terrén, I., Astarloa-Pando, G., Zenarruzabeitia, O., & Borrego, F. (2021) · Cancers · doi:10.3390/cancers13071589 · Cited by 17
Pascal, V., Brunet, C., Pradel, V., Thirion, X., André, P., Faucher, C., Sampol, J., Dignat‐George, F., Blaise, D., Vivier, É., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402670 · Cited by 17
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
Kaufman, H. L., & Wolchok, J. D. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8 · Cited by 18
Kotturi, H. S. R., Li, J., Branham-O’Connor, M., Stickel, S. L., Yu, X., Wagner, T. E., & Wei, Y. (2008) · Gene Therapy · doi:10.1038/gt.2008.77 · Cited by 16
DAP10 Deficiency Breaks the Immune Tolerance against Transplantable Syngeneic Melanoma
Hyka‐Nouspikel, N., Lucian, L., Murphy, E. A., McClanahan, T., & Phillips, J. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3763 · Cited by 16
Albumin-Based Nitric Oxide Traffic System for the Treatment of Intractable Cancers
Ishima, Y. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00867 · Cited by 16
Sourour, S. K. N., Aboelenein, H. R. A., Elemam, N. M., Abdelhamid, A. K., Salah, S., & Abdelaziz, A. I. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13099 · Cited by 16
NKG2D signaling regulates IL-17A-producing γδT cells in mice to promote cancer progression
Curio, S., Edwards, S. C., Suzuki, T., McGovern, J. L., Triulzi, C., Yoshida, N., Jonsson, G., Glauner, T. A., Rami, D., Wiesheu, R., et al. (2022) · Discovery Immunology · doi:10.1093/discim/kyac002 · Cited by 16
Zhang, W., Wang, F., Hu, X., Liang, J., Liu, B., Guan, Q., & Liu, S. (2018) · Oncology Letters · doi:10.3892/ol.2018.9720 · Cited by 15
The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC
Ponath, V., Frech, M., Bittermann, M., Alkhayer, R., Neubauer, A., Brendel, C. A., & von Strandmann, E. P. (2020) · Cancers · doi:10.3390/cancers12102857 · Cited by 15
Prinz, D., Klein, K., List, J., Knab, V. M., Menzl, I., Leidenfrost, N., Heller, G., Polić, B., Putz, E. M., Witalisz‐Siepracka, A., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.201948222 · Cited by 15
Impact of NKG2D Signaling on Natural Killer and T‐Cell Function in Cerebral Ischemia
David, C., Ruck, T., Rolfes, L., Mencl, S., Kraft, P., Schuhmann, M. K., Schroeter, C. B., Jansen, R., Langhauser, F., Mausberg, A. K., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029529 · Cited by 14
Wickström, S. L., Öberg, L., Kärre, K., & Johansson, M. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300960 · Cited by 14
Morvan, M. G., Champsaur, M., Reizis, B., & Lanier, L. L. (2017) · ImmunoHorizons · doi:10.4049/immunohorizons.1700004 · Cited by 14
Self-citationInnate lymphoid cells in early tumor development
Warner, K., Ghaedi, M., Chung, D. C., Jacquelot, N., & Ohashi, P. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.948358 · Cited by 14
Inflammatory Cytokine–Mediated Evasion of Virus-Induced Tumors from NK Cell Control
Mishra, R., Polić, B., Welsh, R. M., & Szomolanyi‐Tsuda, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203328 · Cited by 14
Shaffer, B. C., & Hsu, K. C. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.10.005 · Cited by 13
Lin, Z., Wang, C., Xia, H., Liu, W., Xiao, W., Li, Q., Jia, X., Ding, Y., Ming-chun, J., & Gong, W. (2013) · Immunology · doi:10.1111/imm.12203 · Cited by 13
IL-18 enhances ULBP2 expression through the MAPK pathway in leukemia cells
Song, H., KIM, K., Hur, D., Lim, J., Yang, Y. D., Cho, B. J., Kim, C. H., Kim, T. S., Bang, S., Lee, W. J., et al. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.07.007 · Cited by 13
Savithri, B., & Khar, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200535350 · Cited by 13
Natural killer cells in cancer
Höglund, P., & Klein, E. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.08.002 · Cited by 13
Selvan, S. R., & Dowling, J. P. (2015) · BioMed Research International · doi:10.1155/2015/869547 · Cited by 12
Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy
Niu, Y.-X., Xu, Z., Yu, L., Lu, Y., Wang, Y., Wu, C., Hou, Y.-B., Li, J., Huang, S., Song, X., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108783 · Cited by 12
Macroimmunology and Immunotherapy of Cancer
Hamilton, D. H., Ismail, N., Kroeger, D. R., Rudulier, C. D., & Bretscher, P. A. (2009) · Immunotherapy · doi:10.2217/imt.09.6 · Cited by 12
Lin, F., Dai, C., Ge, X., Tang, W., Lin, Y., Wang, Y., & Li, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.104 · Cited by 12
MicroRNA-34a promotes MICB expression in hepatocytes
Zhou, M., Zhao, C., Chen, X., Zhang, H., Li, G., Lou, H., Huang, W., Wei, L.-J., Li, D., Wu, X., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy128 · Cited by 12
Buhtoiarov, I. N., Rakhmilevich, A. L., Lanier, L. L., Ranheim, E. A., & Sondel, P. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800443 · Cited by 12
Self-citationImmunotherapy of colorectal cancer
Smith, C. S., Dulphy, N., Salio, M., & Cerundolo, V. (2002) · British Medical Bulletin · doi:10.1093/bmb/64.1.181 · Cited by 12
Cell-cell interactions mediating primary and metastatic breast cancer dormancy
Lenart, N. A., & Rao, S. S. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10223-5 · Cited by 11
Kohlhapp, F. J., O’Sullivan, J. A., Moore, T. V., Zloza, A., & Guevara-Patino, J. A. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2022.12.013 · Cited by 11
Lysenko, O., Schulte, D., Mittelbronn, M. G. A., & Steinle, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065345 · Cited by 13
Rojas, J. M., Spada, R., Sanz-Ortega, L., Morillas, L., Mejías, R., Mulens‐Arias, V., Pérez-Yagüe, S., & Barber, D. F. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a1215-541rr · Cited by 11
Ruan, G., Wang, S., Zhu, L., Liao, X., Wang, X., Liao, C., Yan, L., Xie, H., Gong, Y., Gan, J., et al. (2021) · Aging · doi:10.18632/aging.202935 · Cited by 11
Suzuki, D., Tsuji, K., Yamamoto, T., Fujii, K., & Iwatsuki, K. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.06.005 · Cited by 11
Viral escape from NK‐cell‐mediated immunosurveillance: A lesson for cancer immunotherapy?
Momayyezi, P., Bilev, E., Ljunggren, H., & Hammer, Q. (2023) · European Journal of Immunology · doi:10.1002/eji.202350465 · Cited by 10
Wan, L., Zhang, D.-Q., Zhang, J., & Ren, L. (2017) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600369 · Cited by 10
Soluble MICA and anti-MICA Antibodies as Biomarkers of Nasopharyngeal Carcinoma Disease
Chaaben, A. B., Ouni, N., Douik, H., Ayari, F., Abaza, H., Mamoghli, T., Harzallah, L., Fortier, C., Boukouaci, W., Krishnamoorthy, R., et al. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1690506 · Cited by 10
NF-κB p50/p65 Affects the Frequency of Ly49 Gene Expression by NK Cells
Pascal, V., Nathan, N. R., Claudio, E., Siebenlist, U. K., & Anderson, S. K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1751 · Cited by 10
In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity
Nakata, J., Nakano, K., Okumura, A., Mizutani, Y., Kinoshita, H., Iwai, M., Hasegawa, K., Morimoto, S., Fujiki, F., Tatsumi, N., et al. (2013) · Leukemia · doi:10.1038/leu.2013.374 · Cited by 10
“Acquired” NKG2D Ligand Stimulates NK Cell–mediated Tumor Immunosurveillance
Wang, D., Gu, X., Liu, X., Liu, X., Wang, B., Lao, F., & Fang, M. (2019) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000276 · Cited by 9
Chau, J., Moza, D., Hossain, N., Lee, J. K., Bienenstock, J., & Karimi, K. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.050 · Cited by 9
Development of a murine model of lymph node metastases suitable for immunotoxicity studies
Egenolf, D., Rafferty, P., Brosnan, K., Walker, M., Jordan, J. L., Makropoulos, D., Kavalkovich, K. W., Watson, S., Johns, L., Volk, A. L., et al. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.12.001 · Cited by 9
Gong, W., Xiao, W., Li, Q., Gong, C.-X., Hu, M., Pan, X., & Ming-chun, J. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.41 · Cited by 9
Ma, B., Zhang, D.-J., Hu, Y., Chen, X., Gong, R., Lei, K., Yu, Q., & Ren, H. (2023) · Current Gene Therapy · doi:10.2174/1566523223666230720101531 · Cited by 8
Campos‐Silva, C., López-Borrego, S., Felgueres, M. J., Esteso, G., & Valés‐Gómez, M. (2022) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2022045263 · Cited by 8
Increased IFN ‐γ+ and TNF ‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia
Chen, X., Zhang, Y., Zhang, Y., Zhang, Y., Wang, S., Yu, Z. H., Liu, X., Huang, G., Guo, L., Li, X., et al. (2023) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.22115 · Cited by 8
Patil, S., & Schwarer, T. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.02024.x · Cited by 8
Manipulating NK cellular therapy from cancer to invasive fungal infection: promises and challenges
Oh, B. L. Z., Chan, L. W. Y., & Chai, L. Y. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1044946 · Cited by 8
Determining optimal combination regimens for patients with multiple myeloma
Aghaee, M., Ledzewicz, U., Robbins, M. D. H., Bezman, N., Cho, H. J., & Moore, H. A. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106492 · Cited by 8
Correction: Cellular Expression, Trafficking, and Function of Two Isoforms of Human ULBP5/RAET1G
Eagle, R. A., Flack, G., Warford, A., Martínez-Borra, J., Jafferji, I., Traherne, J. A., Ohashi, M., Boyle, L. H., Barrow, A. D., Caillat‐Zucman, S., et al. (2009) · PLoS ONE · doi:10.1371/annotation/34238ee8-5128-4f1d-9ae2-6906c9764e49 · Cited by 8
Serritella, A. V., Larrocha, P. S.-L., Dhar, P., Liu, S., Medd, M. M., Jia, S., Cao, Q., & Wu, J. D. (2024) · Biomedicines · doi:10.3390/biomedicines12010196 · Cited by 7
Crucial immunological roles of the invasion front in innate and adaptive immunity in cervical cancer
Hirahara, Y., Shimizu, K., Yamasaki, S., Iyoda, T., Ueda, S., Sato, S., Harada, J., Saji, H., Fujii, S., Miyagi, E., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02877-3 · Cited by 7
RAC2 inhibition enhances tumor sensitivity to NK cell-mediated cytotoxicity
Guo, H., Hu, J., Wang, Z., Xu, F., Liu, Y., Cui, L., Zhang, H., Xie, C., Yao, R., Jin, H., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010931 · Cited by 7
Cata, J. P., Conrad, C. H., & Rezvani, K. (2015) · Scientifica · doi:10.1155/2015/732438 · Cited by 7
Strategies of Natural Killer (NK) Cell Recognition and Their Roles in Tumor Immunosurveillance
Stewart, C. A., & Vivier, É. (2008) · Springer eBooks · doi:10.1007/978-4-431-73884-8_2 · Cited by 7
SCHLEINITZ, N., Dignat‐George, F., Sampol, J., Harlé, J., & Vivier, É. (2002) · Revue Française des Laboratoires · doi:10.1016/s0338-9898(02)80178-0 · Cited by 7
Immunotherapy of Hepatocellular Carcinoma
Chen, Z., Bian, H., Xing, J., Jiang, J., Li, Y., Yu, X., Wang, L., Yang, X.-M., & Liao, C. (2012) · Springer eBooks · doi:10.1007/978-3-642-28702-2_10 · Cited by 7
Bezouška, K. (2004) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc20040535 · Cited by 7
Geldhof, A. B., Ginderachter, J. A. V., Liu, Y., Noël, W., & BAETSELIER, P. D. (2003) · Journal of Immunology Research · doi:10.1080/10446670310001626580 · Cited by 7
The Role of NK1.1+ Cells in the Protection against MHC Class I+ HPV16-Associated Tumours
Šímová, J., Bubeník, J., Bieblová, J., & Jandlová, T. (2004) · Folia Biologica · doi:10.14712/fb2004050060200 · Cited by 7
ULBPs: regulators of human lymphocyte stress recognition
Zuo, J., Willcox, B. E., & Moss, P. A. H. (2017) · Oncotarget · doi:10.18632/oncotarget.22417 · Cited by 7
Inhibition of thrombin, an unexplored function of retinoic acid
Krishna, T. H. A., Kamalraj, S., Anikisetty, M., Naidu, K. A., Surin, W. R., & Jayabaskaran, C. (2019) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2019.100636 · Cited by 6
NKG2D ligation relieves 2B4‐mediated NK‐cell self‐tolerance in mice
Lee, J. E., Lim, S. A., Kim, T., Kim, K., Ng, J., Kim, Y. H., Jang, I. J., Oh, S. B., Lee, J., Yee, C., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201343724 · Cited by 6
Ahsan, M. R., Mahmud-Al-Rafat, A., Sobhani, M.-E., & Molla, M. A. W. (2013) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-013-0075-y · Cited by 6
Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor model
Barber, M. A., Zhang, T., Gagne, B. A., Ginderachter, J. A. V., BAETSELIER, P. D., & Sentman, C. L. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0404-2 · Cited by 6
Zhao, P., Yang, L., Li, X., Lu, W., Lu, F., Wang, S., Wang, Y., Li, H., Cui, C., Dong, B., et al. (2020) · Cancer Science · doi:10.1111/cas.14434 · Cited by 6
Closa, L., Xicoy, B., Zamora, L., Estrada, N., Colomer, D., Herrero, M. J., Vidal, F., Álvarez‐Larrán, A., & Caro, J. L. (2021) · HLA · doi:10.1111/tan.14515 · Cited by 6
ULBP2 Promotes Tumor Progression by Suppressing NKG2D-Mediated Anti-Tumor Immunity
Yamane, K., Yamaguchi, K., Teruya, Y., Miyake, N., Nakayama, Y., Nonaka, T., Chikumi, H., & Yamasaki, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072950 · Cited by 5
Jin, Y., Guo, Y., Kawano, Y., Sasatani, M., Ohki, S., Yamane, K., Ota, Y., Tamura, Y., Sotomaru, Y., Baba, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1597731 · Cited by 5
Ebihara, T., Azuma, M., Oshiumi, H., Kasamatsu, J., Iwabuchi, K., Matsumoto, K., Saito, H., Taniguchi, T., Matsumoto, M., & Seya, T. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.2009157307012015c · Cited by 5
Epithelial-mesenchymal transition-induced metastasis could be a bait for natural killer cells
Okita, R., Shimizu, K., & Nakata, M. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.08.19 · Cited by 5
The prospect of genetically engineering natural killer cells for cancer immunotherapy
Poon, A. Y. C., & Sugimura, R. (2022) · Biology Open · doi:10.1242/bio.059396 · Cited by 5
Peinado, C. D., Kang, X., Hardamon, C. R., Arora, S., Mah, S., Zhang, H., Ngolab, J., & Bui, J. D. (2013) · Immunology · doi:10.1111/imm.12080 · Cited by 5
Brenner, C. D. (2010) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.11109 · Cited by 5
Srisantitham, J., Thongsin, N., Suwanpitak, S., & Wattanapanitch, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334246 · Cited by 4
Dellalibera-Joviliano, R., Garcia, M. E., Marins, M., Fachin, A. L., Couto, L. B., Mesquita, E., Komoto, T. T., Silva, G., Neto, W. C., Orlando, L. C., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155625 · Cited by 4
Detecting the Unusual: Natural Killer Cells
Volz, A., & Radeloff, B. (2006) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(06)81012-3 · Cited by 4
Steinle, A., & Cerwenka, A. (2015) · Science · doi:10.1126/science.aaa9842 · Cited by 4
Self-citationA Mathematical Model for Tumor–Immune Dynamics in Multiple Myeloma
Gallaher, J. A., Larripa, K., Ledzewicz, U., Renardy, M., Shtylla, B., Tania, N., White, D., Wood, K., Zhu, L., Passey, C., et al. (2018) · Association for Women in Mathematics series · doi:10.1007/978-3-319-98083-6_5 · Cited by 4
Pardoll, D. M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00006-0 · Cited by 5
Jänner, N., Hahnke, K., Mollenkopf, H., Steinhoff, U., Kaufmann, S. H. E., & Mittrücker, H. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02817.x · Cited by 4
FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Duhan, V., Gomez, M. R., Le, T. T., Rana, S., Chen, Y.-C. E., Balakrishnan, D., Kelly, G., Johnston, R. L., Krebs, P., & Khanna, R. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-0174 · Cited by 3
Diefenbach, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394802-1.00004-2 · Cited by 3
Chen, Z., Jin, H., HOU, Y., Wang, B., Chen, C., Yang, Z., Ding, D., Zuo, Y., & Ren, S. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2776 · Cited by 3
Razmkhah, M., Mansourabadi, Z., Mohtasebi, M. S., Talei, A., & Ghaderi, A. A. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_866_16 · Cited by 3
Metadata
- Authors
- Cerwenka, A., Baron, J. L., & Lanier, L. L.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-09-18
- Volume
- 98
- Issue
- 20
- Pages
- 11521-11526
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC58762
- OpenAlex
- W2056645320
- Cited by
- 606
- References
- 34
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 11 · 2023: 11 · 2022: 20 · 2021: 15 · 2020: 24 · 2019: 17 · 2018: 15 · 2017: 26 · 2016: 14 · 2015: 22 · 2014: 27 · 2013: 25 · 2012: 24
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- National Institutes of Health
- National Cancer Institute (CA89189, R01CA089189)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- Rae1, NKG2D, natural killer cells, MHC class I, tumor rejection, missing self, NK cell receptors, immune surveillance, NK1.1+ T cells, tumor rechallenge
- MeSH terms
- Animals, B-Lymphocytes, Female, Immunoglobulin Fc Fragments, Immunologic Memory, Killer Cells, Natural, Lymphocyte Depletion, Lymphoma, Major Histocompatibility Complex, Membrane Proteins, Mice, Inbred C57BL, Recombinant Fusion Proteins, Transfection, Tumor Cells, Cultured, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.